Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2543-2025

IntelliSpace Cardiovascular, Software 8.0.0.4. Recall

IntelliSpace Cardiovascular, Software 8.0.0.4.

FDA recall Class II

Ongoing

FDA lists this Class II recall for IntelliSpace Cardiovascular, Software 8.0.0.4.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2543-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Aug 8, 2025
FDA report date
Sep 17, 2025
Quantity in commerce
4 units
Distribution
See key details
FDA cause
Software design

What is being recalled?

IntelliSpace Cardiovascular, Software 8.0.0.4.

Affected model & UDI checker

Search the exact identifiers published for Z-2543-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
830089IntelliSpace Cardiovascular, Software 8.0.0.4.Check source noticeNot specified
Not specifiedIntelliSpace Cardiovascular, Software 8.0.0.4.Check source notice00884838122000
FDA code information

Model No. 830089; UDI: (01)00884838122000(11)240325(10)8.0.0.0; Serial No. 2210, 2050, 463, 193.

View the original FDA recall notice

Why was this product recalled?

Software issue that results in the display of outdated information.

What actions did PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. take?

An URGENT Medical Device Correction notice dated 8/7/25 was mailed to consignees. The notification includes instructions for continued safe use of devices, which includes: 1. Ensure all finding codes with variables/modifiers are populated correctly on the report screen. Do not leave any FitB Modifier Code Fields Blank. 2. Verify report statements match the selections in the work area before finalizing report. Systems may continue to be used in accordance with the intended use and per the additional instructions. The provided recall notification is to be shared with all users of the device and retained with affected systems until the corrected software is installed. The provided recall response form should be returned within 30 days to Philips.recall@Philips.com. A Philips representative will call consignees to schedule a time to install the software solution (FCO83000218). Consignees with any questions can contact Philips Informatics Customer Support at 1-800-996-1328 (x1).

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology